{"nct_id":"NCT04136366","title":"The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2019-11-15","start_date_type":"ACTUAL","primary_completion_date":"2022-06-14","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ALDX"]}